Molecular Pathology Laboratory Network

Minimal Residual Disease Testing


Detection of minimal residual disease is accomplished through quantitative PCR, a technology that can provide at least 100 to 1000 times greater sensitivity than FISH. Additional studies using gene sequencing also assist in determining acquired drug resistance as is the case in Gleevec®-resistant chronic myeloid leukemia.

Test Information and Specimen Requirements


For more information about minimal residual disease testing, contact one of our service specialists at 800.932.2943.

Our Testing Resources

icon Advanced, complementary technologies
icon Specimen collection for quantitative PCR assays

Minimal Residual Disease Testing Contact Form
Request more info about KRAS

Complete this form to receive more info about KRAS.

Name (*)

Invalid Input
Email (*)

Invalid Input
Message

Invalid Input
Form Validation Code
Form Validation Code

Invalid Input



Journal Articles
 

Follow MPLN

Testing Links

Test Menu
Online Ordering
Requisitions and Forms

Featured Tests

HPV Genotyping
BRAF Mutation Testing
Minimal Residual Disease Testing